Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol

Pediatrics

Volumn 125, Issue 1, 2010, Pages

  Peltola, Heikki ^a   Roine, Irmeli ^b   Fernández, Josefina ^c   Mata, Antonio González ^d   Zavala, Inés ^e   Ayala, Silvia Gonzalez ^f   Arbo, Antonio ^g   Bologna, Rosa ^h   Goyo, José ⁱ   López, Eduardo ^j   Miño, Greta ^k   De Andrade, Solange Dourado ^l   Sarna, Seppo ^m   Jauhiainen, Tapani ⁿ  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSIDAD DIEGO PORTALES   (Chile)

^d School of Medicine   (Dominican Republic)

^e Hospital Pediatrico Dr Agustin Zubillaga   (Venezuela)

^f Hospital de Niños Roberto Gilbert E   (Ecuador)

^g Hospital de Ninos Sor Maria Ludovica   (Argentina)

^h UNIVERSIDAD NACIONAL DE ASUNCIÓN   (Paraguay)

ⁱ Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^j Hospital Universitario de Los Andes   (Venezuela)

^k HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^l Hospital del Niño Francisco de Icaza Bustamante   (Ecuador)

^m Institute for Tropical Diseases   (Brazil)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

Deafness; Dexamethasone; Glycerol; Hearing impairment; Meningitis

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; DEXAMETHASONE; GLUCOSE; GLYCEROL; PLACEBO;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; AUDIOMETRY; BACTERIAL MENINGITIS; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DOUBLE BLIND PROCEDURE; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED BRAIN STEM RESPONSE; FEMALE; GLASGOW COMA SCALE; GLUCOSE BRAIN LEVEL; HAEMOPHILUS INFLUENZAE TYPE B; HEARING ACUITY; HEARING IMPAIRMENT; HUMAN; INFANT; INTRACRANIAL PRESSURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SAMPLE SIZE; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADOLESCENT; AUDIOMETRY; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLYCEROL; HEARING LOSS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MENINGITIS, BACTERIAL; MENINGITIS, HAEMOPHILUS; MENINGITIS, PNEUMOCOCCAL; ODDS RATIO; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 74049150519     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0395     Document Type: Article

References (40)

1. Duke T, Mokela D, Frank D, et al. Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomized trial. Ann Trop Paediatr. 2002;22(2):145-157
2. Fortnum H, Davis A. Hearing impairment in children after bacterial meningitis: incidence and resource implications. Br J Audiol. 1993;27(1):43-52
3. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13(2):302-317
4. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19(3):187-195
5. Kaplan SL, Catlin FI, Weaver T, Feigin RD. Onset of hearing loss in children with bacterial meningitis. Pediatrics. 1984;73(5):575-578
6. Wald ER, Kaplan SL, Mason EO, et al. Dexamethasone therapy for children with bacterial meningitis. Pediatrics. 1995;95(1):21-28
7. Grimwood K, Anderson P, Anderson C, Tan L, Nolan T. Twelve-year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83(2):111-116
8. Berlow SJ, Caldarelli DD, Matz GJ, et al. Bacterial meningitis and sensorineural hearing loss: a prospective investigation. Laryngoscope. 1980;90(9):1445-1452
9. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med. 1984;311(14):869-874
10. Fortnum HM. Hearing impairment after bacterial meningitis: a review. Arch Dis Child. 1992;67(9):1128-1133
11. McIntyre PB, MacIntyre CR, Gilmour R, Wang H. A population-based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child. 2005;90(4):391-396
12. Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S. Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. 2006;132(9):941-945
13. Basualdo W, Arbo A. Invasive Haemophilus influenzae type b infections in children in Paraguay. Arch Med Res. 2004;35(2):126-133
14. Obiako MN. Profound childhood deafness in Nigeria: a three year survey. Ear and Hearing. 1987;8(2):74-77
15. Salih MAM, Khaleefa OH, Bushara M, et al. Long-term sequelae of childhood acute bacterial meningitis in a developing country: a study from The Sudan. Scand J Infect Dis. 1991;23(2):175-182
16. Daoud AS, Al-Sheyyab M, Batchoun RG, et al. Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood. J Trop Med Paed. 1995;41:308-310
17. Feris J, Fernández J, Pena TC, et al. Factors associated with hearing loss in Dominican children with bacterial meningitis. In: Abstract Book of the 3rd World Congress of Pediatric Infectious Diseases (WSPID). Santiago, Chile: 3rd World Congress of Pediatric Infectious Diseases (WSPID); 2002:57
18. Olusanya BO, Newton VE. Global burden of childhood hearing impairment and disease control priorities for developing countries. Lancet. 2007;369(9569):1314-1317
19. Peltola H, Anttila M, Renkonen OV. The Finnish Study Group: randomized comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet. 1989;1(8650):1281-1287
20. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebocontrolled trials. N Engl J Med. 1988;319(15):964-967
21. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1989;160(5):818-825
22. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324(22):1525-1531
23. Schaad UB, Lips U, Gnehm HE, Blumberg A, Wedgwood J. The Swiss Meningitis Study Group: dexamethasone therapy for bacterial meningitis in children. Lancet. 1993;342(8869):457-461
24. Sáez-Llorens X, McCracken G Jr. Antimicrobial and anti-inflammatory treatment of bacterial meningitis. Infect Dis Clin North Am. 1999;13(3):619-636
25. Peltola H, Roine I, Fernández J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007;45(10):1277-1286
26. Roine I, Saukkoriipi A, Leinonen M, Peltola H, LatAm Meningitis Study Group. Microbial genome count in cerebrospinal fluid compared with clinical characteristics in pneumococcal and Haemophilus influenzae type b meningitis in children. Diagn Micro Infect Dis. 2009;63(1):16-23
27. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Lancet. 2002;360(9328):211-218
28. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2007;(1):CD004405
29. Roine I, Peltola H, Fernández J, et al. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis. 2008;46(8):1248-1252
30. Herson VC, Todd JK. Prediction of morbidity in Haemophilus influenzae meningitis. Pediatrics. 1977;59(1):35-39
31. Buckell M, Walsh L. Effect of glycerol by mouth on raised intracranial pressure in man. Lancet. 1964;2(7370):1151-1152
32. Cantore GP, Guidetti B, Virno M. Oral glycerol for the reduction of intracranial pressure. J Neurosurg. 1964;21:278-283
33. Meyer JS, Charney JZ, Rivera VM, Mathew NT. Treatment with glycerol of cerebral oedema due to acute cerebral infarction. Lancet. 1971;2(7732):993-997
34. Frank MSB, Nahata MC, Hilty MD. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy. 1981;1(2):147-160
35. Sommer S, Nau R, Wieland E, Prange HW. Pharmacokinetics of glycerol administered orally in healthy volunteers. Arzneimittelforschung. 1993;43(7):744-747
36. Kilpi T, Peltola H, Kallio MK, et al. Oral glycerol versus intravenous dexamethasone in preventing hearing impairment due to childhood bacterial meningitis. Pediatr Infect Dis J. 1995;14(4):270-278
37. Syrogiannopoulos GA, Lourida AN, Theodoridou MC, et al. Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J Infect Dis. 1994;169(4):853-858
38. Jennett B, Teasdale G. Aspects of coma after severe head injury. Lancet. 1977;1(8017):878-881
39. Peltola H. Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J. 1997;16(8):780-787
40. Mai NTH, Chau TTH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007;357(24):2431-2440